Matthew Bui
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
-
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 18
-
- Renal and related cancers 10
- Co-authors
- Arie S. Belldegrun (19 shared papers)Robert A. Figlin (16 shared papers)Gary R. Whittaker (6 shared papers)Ari Helenius (4 shared papers)Allan J. Pantuck (12 shared papers)David B. Seligson (11 shared papers)Steve Horvath (10 shared papers)Frederick J. Dorey (6 shared papers)
- Journals
- The Journal of Urology (10 papers)Clinical Cancer Research (3 papers)Urology (3 papers)Journal of Virology (3 papers)Cancer (2 papers)
- Partner nations
- United StatesAustraliaThailand
In The Last Decade
Matthew Bui
40 papers receiving 2.8k citations
Matthew Bui's Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 752
- Pulmonary and Respiratory Medicine 1.6k
- Molecular Biology 1.7k
- Oncology 523
- Epidemiology 577
Countries citing papers authored by Matthew Bui
This map shows the geographic impact of Matthew Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Bui more than expected).
Fields of papers citing papers by Matthew Bui
This network shows the impact of papers produced by Matthew Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Bui. The network helps show where Matthew Bui may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Bui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Hit paper breakdown → | 2003 | 514 |
| 2 | 2004 | 183 | |
| 3 | 1996 | 179 | |
| 4 | 2005 | 162 | |
| 5 | 2000 | 160 | |
| 6 | 2003 | 159 | |
| 7 | 2004 | 146 | |
| 8 | 2003 | 141 | |
| 9 | 2005 | 123 | |
| 10 | 1996 | 108 | |
| 11 | 2004 | 100 | |
| 12 | 2003 | 96 | |
| 13 | 1996 | 95 | |
| 14 | 2003 | 93 | |
| 15 | 2003 | 89 | |
| 16 | 1996 | 71 | |
| 17 | 1998 | 47 | |
| 18 | 2009 | 46 | |
| 19 | 2014 | 44 | |
| 20 | Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene. | 2003 | 41 |
About Matthew Bui
Matthew Bui is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 42 papers that have together received 2.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (18 papers), Renal and related cancers (10 papers), Cancer Genomics and Diagnostics (6 papers), Virus-based gene therapy research (5 papers), Influenza Virus Research Studies (5 papers), Cancer Research and Treatments (4 papers), Organ Donation and Transplantation (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Cancer Research (752 citations), Pulmonary and Respiratory Medicine (1.6k citations), Molecular Biology (1.7k citations), Oncology (523 citations) and Epidemiology (577 citations). Matthew Bui has collaborated with scholars based in United States, Australia and Thailand. Frequent co-authors include Arie S. Belldegrun, Robert A. Figlin, Gary R. Whittaker, Ari Helenius, Allan J. Pantuck, David B. Seligson, Steve Horvath, Frederick J. Dorey, Ken‐ryu Han and Bradley C. Leibovich. Their work appears in journals such as The Journal of Urology, Clinical Cancer Research, Urology, Journal of Virology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.